4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001618670-26-000004
Chief Financial Officer sold 6,798 shares at $38.69 ($263,015)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Girao Tiago Chief Financial Officer | 2026-07-23 | Sale | −6,798 | $38.69 | $263,015 | 240,798 | D |
| Open-market sales · 6,798 sh · avg $38.69 · $263,015 | |||||||
Loading xslF345X06/wk-form4_1784930275.xml…